Targeted radiation therapies (TRT) deliver cytotoxic radiation selectively to tumors. In recent years, oncology drug developers have increased their interest in this therapeutic class. However, the regulatory landscape is still…
Breaking down the basics of CDISC’s CDASH, SDTM and ADaM standards, to help you understand how they work and how to use them.
RADNOR, PA – May 21, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran…
In this abstract, Julie Ann Hood and Jennifer Manzi look at how you can improve your SDTM Validation with the magic of Data Managers.
This case study explores how one biopharma gets deeper insights & more informed decision making by standardizing their clinical trial design.
In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies deliver cytotoxic small-molecule drug payloads to cancer cells. The cytotoxic payload attaches to a monoclonal…
Partnership will provide biopharmaceutical companies with advanced tools and solutions needed to expedite research RADNOR, PA – May 10, 2024 – Certara, Inc., a global leader in model-informed drug…
© 2025 Certara. All Rights Reserved. | Privacy policy
